Medifast Inc
Organization details
- Legal name
- Medifast Inc
- Former names
- Healthrite Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Consumer Staples
- SIC code
- 2090 — Miscellaneous Food Preparations & Kindred Products
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Baltimore
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MED
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000910329
- EIN
- 13-3714405
- Wikidata ID
- Q6806861
Board of directors
-
Andrea B. Thomas · DirectorSince 2023
-
Constance J. Hallquist · DirectorSince 2023
-
Daniel R. Chard · Director · Chairman & CEOSince 2023
-
Elizabeth A. Geary · DirectorSince 2023
-
Jeffrey J. Brown · DirectorSince 2023
-
Jeffrey Matthew Rose · DirectorSince 2026
-
Michael A. Hoer · DirectorSince 2023
-
Ming Xian · DirectorSince 2023
-
Parsa Kiai · DirectorSince 2026
-
Scott Schlackman · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.9%
-
91.9%
-
92.3%
-
93.0%
-
94.4%
-
94.4%
-
94.9%
Board connections
1 of this board's directors also sit on 1 other board.
- via Jeffrey J. Brown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,741,888
- 14 purchases by 3 insiders
- Sold, last 12 months
- $226,300
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Parsa Kiai Director | Open-market purchase | +661 | $13.03 | $8,610 |
| Oct 28, 2026 | Parsa Kiai Director | Open-market purchase | +5,399 | $12.24 | $66,093 |
| Oct 28, 2026 | Parsa Kiai Director | Open-market purchase | +158 | $12.24 | $1,934 |
| Sep 29, 2026 | Daniel R. Chard Director | Open-market sale | −9,544 | $11.73 | $111,951 |
| Sep 28, 2026 | Daniel R. Chard Director | Open-market sale | −9,545 | $11.98 | $114,349 |
| Aug 26, 2026 | Parsa Kiai Director | Open-market purchase | +41,975 | $12.26 | $514,614 |
| Aug 26, 2026 | Parsa Kiai Director | Open-market purchase | +1,175 | $12.26 | $14,406 |
| Aug 24, 2026 | Parsa Kiai Director | Open-market purchase | +4,211 | $12.00 | $50,532 |
| Aug 24, 2026 | Parsa Kiai Director | Open-market purchase | +118 | $12.00 | $1,416 |
| Aug 20, 2026 | Parsa Kiai Director | Open-market purchase | +41,975 | $11.60 | $486,910 |
| Aug 20, 2026 | Parsa Kiai Director | Open-market purchase | +1,175 | $11.60 | $13,630 |
| Aug 19, 2026 | Parsa Kiai Director | Open-market purchase | +28,538 | $11.66 | $332,753 |
| Aug 19, 2026 | Parsa Kiai Director | Open-market purchase | +799 | $11.66 | $9,316 |
| May 26, 2026 | Jeffrey Matthew Rose Director | Grant or award | +11,680 | — | — |
| May 26, 2026 | Parsa Kiai Director | Grant or award | +11,680 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Medifast Inc
Who is the CEO of Medifast Inc?
Daniel R. Chard is Medifast Inc's Chairman & CEO.
How many directors are on Medifast Inc's board?
Medifast Inc's board has 10 directors: Andrea B. Thomas, Constance J. Hallquist, Daniel R. Chard, Elizabeth A. Geary, Jeffrey J. Brown, Jeffrey Matthew Rose, Michael A. Hoer, Ming Xian, Parsa Kiai and Scott Schlackman.
Are Medifast Inc insiders buying or selling shares?
Over the last 12 months, Medifast Inc insiders bought $1.7 million of shares in 14 purchases and sold $226,300 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="medifast-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.